Sanolium AB interim report, January - March 2022

CEO’s Comments

Growing demand for our solutions reflects the need for increased digitalization in health and social

care. The Nordic regions and municipalities need to invest more in IT than they have done historically.

Cambio has the products and services to bridge the technical gap that the regions and municipalities

face, and to enable tomorrow’s health and social care. Together with our customers, we contribute to a

better and healthier society. [Read more in the full report]

Revenue in the first quarter amounted to 244.1 MSEK, representing a growth of 18.9%

Q1, January - March 2023

• Revenue amounted to 244,1 (205,3) MSEK in the

first quarter, representing a growth of 18,9%

• Adjusted EBITDA amounted to 40,0 (58,2) MSEK,

representing a decrease of -31,3%

• Income before tax amounted to -29.5 (-27.7) MSEK

• Net income per share amounted to -0.18 (0.14) SEK

For further information, please contact: 

Rami Avidan
CEO
+46 070 793 483 
rami.avidan@cambio.se

Johannes Fabó
CFO
+46 730 599 368
johannes.fabo@cambio.se

Sanolium AB, parent of the Cambio Group (“Cambio” or “the Company”) operating entities, is an e-health company providing comprehensive IT solutions to improve healthcare and patient safety. Cambio is one of the largest suppliers in Scandinavia and a growing player in the European market, with more than 170,000 users across regions and municipalities, general and university hospitals, health centers and specialist units. Cambio has offices in Sweden, Denmark, United Kingdom and Sri Lanka.